24-Hour Post-Acute Ischemic Stroke Management
Administer aspirin 160-300 mg orally within 24-48 hours after stroke onset for all patients who did not receive IV thrombolysis (tPA). 1
Antiplatelet Therapy Algorithm
For Patients Who Did NOT Receive IV tPA or Thrombectomy:
- Start aspirin immediately after brain imaging excludes hemorrhage and dysphagia screening is passed
- Dose: 160-300 mg (guidelines previously specified 325 mg but trials used 160-300 mg range) 1
- Route: Oral preferred; rectal suppository (325 mg) or enteral tube (80 mg) if dysphagia present 2
- Primary benefit: Reduces early recurrent stroke, not limitation of initial stroke damage 3
For Patients Who RECEIVED IV tPA or Thrombectomy:
- Delay aspirin for 24 hours after treatment 1, 2
- Obtain 24-hour post-thrombolysis brain imaging to exclude intracranial hemorrhage before starting antiplatelet therapy 2
- Then initiate aspirin 81-325 mg daily 1
For Minor Stroke Patients (Low NIHSS):
- Consider dual antiplatelet therapy (aspirin + clopidogrel) started within 24 hours 1
- Duration: 21 days of dual therapy for secondary prevention up to 90 days
- Class IIa recommendation with moderate evidence 1
- Do NOT use ticagrelor over aspirin (Class III recommendation) 1
Anticoagulation Management
Do NOT initiate anticoagulation within 24 hours of IV tPA (Class III recommendation) 3
General Anticoagulation Principles:
- Urgent anticoagulation is NOT recommended for preventing early recurrent stroke or halting neurological worsening (Class III, Level A) 3
- Avoid anticoagulation in moderate-to-severe strokes due to increased intracranial hemorrhage risk 3
- Early anticoagulation does NOT reduce early recurrent stroke risk and increases bleeding complications 3
Specific Clinical Scenarios:
- Severe carotid stenosis: Usefulness of urgent anticoagulation not established (Class IIb) 1, 3
- Arterial dissection or vertebrobasilar disease: Effectiveness not established 3
- Cardioembolic sources: Timing of anticoagulation initiation remains uncertain; balance individual risk vs. benefit 1
Blood Pressure Management (First 24 Hours)
For Patients WITHOUT Reperfusion Therapy:
- Avoid aggressive BP lowering unless SBP ≥220 mmHg or DBP ≥120 mmHg 4
- If treatment needed: Reduce by no more than 20% over first 24 hours 4
- Target: Maintain BP >220/120 mmHg 4
For Patients WITH IV tPA or Thrombectomy:
- Pre-treatment: BP must be <185/110 mmHg 1
- Post-treatment (0-24 hours): Maintain BP <180/105 mmHg 1, 2
- Critical: Higher peak systolic BP correlates with worse 90-day outcomes and increased hemorrhagic complications 5
Monitoring and Mobilization
Neurological Monitoring:
- Intensive monitoring for first 12 hours post-treatment 6
- Patients stable at 12 hours with low NIHSS rarely deteriorate between 12-24 hours 6
- Frequency: Every 15 min × 2 hours, then every 30 min × 6 hours, then hourly 6
Early Mobilization:
- Begin mobilization within 24-48 hours for neurologically and hemodynamically stable patients 7, 8
- Class IIa recommendation: Safe and feasible within first 24 hours 7
- Evidence shows improved lower extremity function when started 24-48 hours vs. 72-96 hours 8
- Even patients with depressed consciousness can be mobilized to chair if stable 7
Critical Pitfalls to Avoid
Never substitute aspirin for acute reperfusion therapy (tPA or thrombectomy) - Class III recommendation 1
Do not give antiplatelet agents within 24 hours of tPA - increases hemorrhage risk without proven benefit 1, 3
Avoid glycoprotein IIb/IIIa inhibitors (abciximab) - potentially harmful (Class III: Harm) 1
Do not aggressively lower BP in non-thrombolyzed patients - may worsen penumbral perfusion 4
Verify dysphagia screening before oral aspirin administration to prevent aspiration 2, 7